Bristol Myers Squibb Co. (BMY)
61.36
-1.56
(-2.49%)
USD |
NYSE |
Nov 17, 16:00
60.97
-0.40
(-0.64%)
After-Hours: 20:00
Bristol Myers Squibb Price : 61.36 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 64.94 | 64.94 | 62.82 | 62.93 | 10.000M |
| Nov 13, 2026 | 62.56 | 63.78 | 61.81 | 63.43 | 9.274M |
| Nov 12, 2026 | 63.80 | 64.12 | 62.31 | 62.32 | 9.390M |
| Nov 11, 2026 | 62.00 | 62.96 | 61.31 | 62.91 | 6.430M |
| Nov 10, 2026 | 61.67 | 62.92 | 61.30 | 62.80 | 7.617M |
| Nov 09, 2026 | 62.88 | 63.06 | 61.80 | 62.14 | 7.668M |
| Nov 06, 2026 | 61.46 | 63.06 | 61.32 | 62.14 | 9.796M |
| Nov 05, 2026 | 65.00 | 65.54 | 62.98 | 63.13 | 9.027M |
| Nov 04, 2026 | 63.19 | 64.24 | 62.26 | 64.19 | 14.13M |
| Nov 03, 2026 | 63.02 | 63.26 | 61.54 | 61.71 | 10.29M |
| Nov 02, 2026 | 62.45 | 63.14 | 62.17 | 63.02 | 10.84M |
| Oct 30, 2026 | 63.00 | 64.05 | 62.28 | 62.48 | 12.67M |
| Oct 29, 2026 | 61.00 | 61.56 | 60.00 | 61.39 | 14.77M |
| Oct 28, 2026 | 60.50 | 61.34 | 60.33 | 60.57 | 7.413M |
| Oct 27, 2026 | 61.21 | 61.64 | 60.92 | 61.55 | 7.778M |
| Oct 26, 2026 | 61.39 | 62.06 | 61.11 | 61.61 | 7.845M |
| Oct 23, 2026 | 62.66 | 62.84 | 61.31 | 61.48 | 9.763M |
| Oct 22, 2026 | 61.46 | 63.59 | 61.04 | 63.00 | 15.17M |
| Oct 21, 2026 | 61.50 | 61.81 | 60.68 | 61.12 | 9.016M |
| Oct 20, 2026 | 59.93 | 61.82 | 59.83 | 61.68 | 11.91M |
| Oct 19, 2026 | 59.40 | 59.87 | 58.44 | 58.83 | 11.55M |
| Oct 16, 2026 | 61.10 | 61.43 | 59.54 | 59.75 | 13.77M |
| Oct 15, 2026 | 60.67 | 62.25 | 60.39 | 60.57 | 13.75M |
| Oct 14, 2026 | 56.81 | 59.38 | 56.58 | 59.28 | 14.05M |
| Oct 13, 2026 | 57.78 | 58.02 | 56.15 | 56.67 | 16.96M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 279.00 |
| Eli Lilly & Co. | 1410.01 |
| Merck & Co., Inc. | 143.29 |
| Pfizer Inc. | 28.46 |
| AstraZeneca PLC | 182.24 |
Price Related Metrics
| PE Ratio | 13.60 |
| PS Ratio | 2.510 |
| PEG Ratio | 0.2595 |
| Price to Book Value | 5.359 |
| Price to Free Cash Flow | 13.53 |
| Earnings Yield | 7.35% |
| Market Cap | 125.43B |
| PEGY Ratio | 0.2411 |
| Operating PE Ratio | 7.623 |
| Normalized PE Ratio | 9.612 |